Drugs / BLS-ILB-E710c
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03274206 | Aug 2017 → Aug 2020 | cervical intraepithelial neoplasia grade 2/3 | BioLeaders Corporation | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BLS-ILB-E710c | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03274206 ↗ |